PATENT CLAIM ANALYSIS

Application Number: 16017248
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2019-05
Patent Classification: ["546", "275400"]

Abstract:
Provided are substituted benzaldehydes and derivatives thereof that act as allosteric modulators of hemoglobin, methods and intermediates for their preparation, pharmaceutical compositions comprising the modulators, and methods for their use in treating disorders mediate by hemoglobin and disorders that would benefit from increased tissue oxygenation.

Claim (Index 21):
The compound of  claim 18 , wherein Q is substituted with one R a .

Metadata:
- Claim Count in Document: 29.0
- Percentile: 94.0
- Lexical Diversity: 1.32432
- Patent Class: 546.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['13730674', '13730730', '15864433', '13815770', '15852406']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7773142986170732
- 35 USC 102 Novelty (BERT): 0.5161274078980028
- Combined Prediction Score: 0.7511956095451662
- Mean Citation Score: 281.294182
- Max Citation Score: 281.99356
- Similarity Product: 185.4483063131976

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test